跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIXTRA 2,5 MG/0,5 ML SOLUCION INYECTABLE, JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ARIXTRA 2,5 MG/0,5 ML SOLUCION INYECTABLE, JERINGA PRECARGADA
Approved
STANDARD
ARIXTRA 2,5 MG/0,5 ML SOLUCION INYECTABLE, JERINGA PRECARGADA
Viatris Healthcare Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 17, 2025
Approval ID
c35e4f0a88bc7b63
Company
Viatris Healthcare Limited
Type
Standard
Approval Details
Approval Id
c35e4f0a88bc7b63
Drug Cima Aemps Name
ARIXTRA 2,5 MG/0,5 ML SOLUCION INYECTABLE, JERINGA PRECARGADA
Register Number
02206003IP1
Holder Company Name
Viatris Healthcare Limited
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/viatris-healthcare
Authorization Date
2025-06-17
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
2,5mg/0,5ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Viatris Healthcare Limited
Company Detail Path
/organization/viatris-healthcare
Company Information
Pharmaceutical Company Name
VIATRIS HEALTHCARE
Country Name
France
City Name
lyon,auvergne rhone alpes,country_fr
Address
1 RUE DE TURIN
Active Ingredients
FONDAPARINUX SODICO
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 17, 2025
Approval ID
c35e4f0a88bc7b63
Type
Standard
Back to CIMA-AEMPS Approvals